Couragene
Novel Delivery Platforms, Breakthrough Therapies
United States · $40.0M raised
- Website
- couragene.com
- Total Funding
- $40.0M
- Last Round
- $40.0M GrantSep 2024
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Couragene develops gene and biologic therapies using proprietary delivery platforms intended to address the difficulty of delivering genetic medicines to targeted cells in vivo. Its work spans non-viral delivery of genome-editing machinery, DNA, RNA, and other biologics. The biotechnology company is advancing disease programs and aims to make genetic-medicine delivery safer and more efficient.
Summary
Couragene is a Biotech company based in United States. It has raised $40.0M in total across 1 round, most recently a $40.0M Grant round in Sep 2024.
Funding History
Sep 2024
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/couragene"><img src="https://indexed.vc/api/badge/company/couragene" alt="Couragene on Indexed.vc" width="260" height="76" /></a>